Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Melania Baio
Observed names:
S Baio,
S. Baio,
S. M. Baio,
S.M. Baio,
Silvia Baio,
Silvia M Baio,
Silvia M. Baio
show all 7
Institution:
SUNY Upstate Medical University
Observed institutions:
SUNY Upstate Medical University,
Servier (France),
Fondazione IRCCS Istituto Nazionale dei Tumori,
Institut de Recherches Internationales Servier (France),
European Institute of Oncology
OpenAlex ID:
A5111536455
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
2008
·
Lisa Bodei
, Marta Cremonesi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
438
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
2011
·
Lisa Bodei
, Marta Cremonesi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
435
Safety of sentinel node biopsy in pregnant patients with breast cancer
2004
·
O. Gentilini
, M. Cremonesi
, et al.
·
Annals of Oncology
·
230
PDF
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
2009
·
Mirco Bartolomei
, Lisa Bodei
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
151
Long-term results of PRRT in advanced bronchopulmonary carcinoid
2015
·
Annapaola Mariniello
, Lisa Bodei
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
122
Sentinel node biopsy in male breast cancer
2004
·
Concetta De Cicco
, Silvia M. Baio
, et al.
·
Nuclear Medicine Communications
·
68
Yttrium-labelled peptides for therapy of NET
2012
·
Lisa Bodei
, Marta Cremonesi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
55
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
2008
·
Lisa Bodei
, Marta Cremonesi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
29
PDF
Nuclear Medicine Advances in Breast Cancer Imaging
2001
·
Emilio Bombardieri
, Flavio Crippa
, et al.
·
Tumori Journal
·
14
Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response
2007
·
Laura Lavinia Travaini
, Silvia Melania Baio
, et al.
·
The Breast
·
13
Pretargeted antibody‐guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphoma
2007
·
Giuseppe Palumbo
, Chiara M. Grana
, et al.
·
European Journal Of Haematology
·
10
Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy.
2017
·
Giovanni Corso
, Chiara Maria Grana
, et al.
·
PubMed
·
9
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: Preliminary report of a French multicentre phase II trial
1994
·
A. Rivière
, A. Le Cesne
, et al.
·
European Journal of Cancer
·
8
Clinical Utility of 99m Tc-Sestamibi Scintimammography in the Management of Equivocal Breast Lesions
2004
·
Concetta De Cicco
, Giuseppe Trifirò
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
5
Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues: ten years experience
2008
·
Lisa Bodei
, Chiara M. Grana
, et al.
·
Biomedicine & Pharmacotherapy
·
1
Pancreas after kidney transplantation, is it the time to overcome the stigma?
2024
·
M. Moein
, B. Maloney
, et al.
·
HPB
PDF
3-Step radioimmunotherapy (RIT) in high-grade glioma: 11 Years experience with the avidin-biotin system
2010
·
Chiara Maria Grana
, Silvia M. Baio
, et al.
·
Journal of Nuclear Medicine
Right pelvic mass in a patient with a radically resected carcinoid of the appendix
2009
·
N Fazio
, F Luca
, et al.
·
Gut
Show more works
View as search
Works count:
19
Citation count:
1,588
H-index:
10
I10-index:
11
Year
Topic
Type
